Clinical Trials Directory

Trials / Completed

CompletedNCT00128167

Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age

A Randomized, Double-Blind Trial to Assess the Safety and Relative Efficacy of CAIV-T Against Inactivated Influenza Vaccine in Children 6-59 Months of Age

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
8,500 (planned)
Sponsor
MedImmune LLC · Industry
Sex
All
Age
6 Months – 59 Months
Healthy volunteers
Accepted

Summary

The primary objective of this study is to estimate the relative efficacy and assess the safety of CAIV-T compared to TIV.

Conditions

Interventions

TypeNameDescription
DRUGLiquid CAIV-T

Timeline

Start date
2004-10-01
Completion
2005-12-01
First posted
2005-08-09
Last updated
2021-09-13

Locations

161 sites across 8 countries: United States, Belgium, Czechia, Hong Kong, Ireland, South Korea, Taiwan, United Kingdom

Source: ClinicalTrials.gov record NCT00128167. Inclusion in this directory is not an endorsement.